Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit

被引:31
作者
Ruiz-Moreno, Jose M.
Montero, Javier A.
Bayon, Alejandro
Rueda, Joaquin
Vidal, Manuel
机构
[1] Miguel Hernandez Univ, Sch Med, Dept Ophthalmol, Alicante 03550, Spain
[2] VISSUM, Alicante Inst Ophthalmol, Alicante 03015, Spain
[3] Univ Murcia, Vet Clin Hosp, Sch Vet, Ophthalmol Serv, E-30100 Murcia, Spain
[4] Miguel Hernandez Univ, Sch Med, Dept Anat & Histol, Alicante 03550, Spain
[5] Univ Murcia, Sch Med, Dept Ophthalmol, E-30100 Murcia, Spain
关键词
corticosteroid; rabbit; retina; toxicity; triamcinolone acetonide;
D O I
10.1016/j.exer.2006.10.006
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
In order to study acute retinal toxicity of intravitreal triamcinolone acetonide (TA) at high doses in an animal model, thirty New Zealand albino rabbits were injected with intravitreal TA. The animals were divided in five groups: Group 1 received an intravitreal injection of 0.1 mL balanced salt solution; Group 2, 0.1 mL of the solvent (0.99 mg of benzyl alcohol); Group 3, received 4 mg/0.1 mL TA; Group 4, 20 mg/0.1 mL TA; and Group 5, 30 mg/0.1 mL TA. A standard light and dark adapted electroretinogram (ERG) was obtained prior and 28 days after the injection. The animals were sacrificed 28 days after the injection and the eyes were enucleated and examined by electron (EM) and light microscopy (LM) using hematoxylin-eosin, Nissl fluorescent, and immunohistochemistry (glial fibrillary acidic protein). No statistically significant differences in ERG before and 28 days after the injection were found. LM and EM did not show retinal damage in any animal. One eye developed bacterial endophthalmitis 14 days after the injection. Intravitreal TA up to 30 mg does not seem to have acute toxic effects on the function (ERG) or the structure (LM, EM) of the retina of albino rabbits. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:342 / 348
页数:7
相关论文
共 30 条
[1]   Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: Functional and anatomic results [J].
Boscia, F ;
Furino, C ;
Dammacco, R ;
Ferreri, P ;
Sborgia, L ;
Sborgia, C .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2005, 15 (01) :89-95
[2]  
BROWN WJ, 1982, LANCET, V1, P1250
[3]   Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion [J].
Çekiç, O ;
Chang, S ;
Tseng, JJ ;
Barile, GR ;
Weissman, H ;
Del Priore, LV ;
Schiff, WM ;
Weiss, M ;
Klancnik, JM .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (07) :846-850
[4]   Intravitreal injection of triamcinolone acetonicle as treatment for chronic uveitis [J].
Degenring, RF ;
Jonas, JB .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (03) :361-361
[5]   Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina [J].
Dierks, D ;
Lei, B ;
Zhang, KQ ;
Hainsworth, DP .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (11) :1563-1569
[6]   Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections [J].
Ferrer, C ;
Colom, F ;
Frasés, S ;
Mulet, E ;
Abad, JL ;
Alió, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) :2873-2879
[7]   A Randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration - One year results [J].
Gillies, MC ;
Simpson, JM ;
Luo, W ;
Penfold, P ;
Hunyor, ABL ;
Chua, W ;
Mitchell, P ;
Billson, F .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (05) :667-673
[8]  
HARDMAN J, 2001, GOODMAN GILMANS PHAR, P1673
[9]   EXPERIMENTAL AND CLINICAL OBSERVATIONS OF THE INTRAOCULAR TOXICITY OF COMMERCIAL CORTICOSTEROID PREPARATIONS [J].
HIDA, T ;
CHANDLER, D ;
ARENA, JE ;
MACHEMER, R .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 101 (02) :190-195
[10]   Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases [J].
Jonas, JB ;
Kreissig, I ;
Degenring, R .
PROGRESS IN RETINAL AND EYE RESEARCH, 2005, 24 (05) :587-611